Jensen Investment Management’s ResMed RMD Stock Holding History

Jensen Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,720	Closed	-$1.73M	–	84
2023 Q3	$1.73M	Sell	11,720 -11,370	-49%	-$2.06M	0.01%	77
2023 Q2	$5.05M	Buy	23,090 +3,440	+18%	+$767K	0.04%	58
2023 Q1	$4.24M	Buy	19,650 +2,180	+12%	+$473K	0.03%	63
2022 Q4	$3.64M	Sell	17,470 -770	-4%	-$169K	0.03%	67
2022 Q3	$3.98M	Hold	18,240	–	–	0.03%	60
2022 Q2	$3.82M	Buy	18,240 +2,700	+17%	+$575K	0.03%	61
2022 Q1	$3.77M	Buy	15,540 +7,580	+95%	+$1.83M	0.03%	66
2021 Q4	$2.07M	Buy	+7,960	New	+$2.07M	0.01%	71

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jensen Investment Management's RMD Position: Q4 2023 in Review

Jensen Investment Management sold out of ResMed (RMD) in Q4 2023, closing a stake of 11,720 shares — an estimated $1.73M sold.

Jensen Investment Management first reported a position in RMD in Q4 2021 and held it in 8 quarters. The position peaked at $5.05M in Q2 2023. 687 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

Jensen Investment Management reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
Jensen Investment Management sold 11,720 ResMed shares in Q4 2023, an estimated $1.73M.
Jensen Investment Management first reported a position in ResMed in Q4 2021 and held it in 8 quarters.
Jensen Investment Management's ResMed position peaked at $5.05M in Q2 2023.
687 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Jensen Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.